Claude LeBlanc compensation by year
OCTAVE SPECIALTY Summary Compensation Table · all 9 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Salary | $900,000 | $900,000 | $900,000 | $900,000 | $900,000 | $900,000 | $900,000 | $900,000 | $900,000 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $900,000 |
| Stock awards | $0 | $4,117,020 | $3,005,464 | $3,285,787 | $4,358,942 | $3,420,095 | $4,125,142 | $3,788,006 | $6,108,742 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1,467,000 |
| Non-equity incentive | $1,081,000 | $1,170,000 | $1,657,000 | $1,795,500 | $1,699,000 | $1,827,000 | $1,851,500 | $1,619,900 | $945,000 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $5,898 | $15,987 | $25,772 | $30,214 | $21,373 | $38,667 | $41,077 | $32,814 | $35,486 |
| Total | $1,986,898 | $6,203,007 | $5,588,236 | $6,011,501 | $6,979,315 | $6,185,762 | $6,917,719 | $6,340,720 | $10,356,228 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCTAVE SPECIALTY GROUP INC DEF 14A filed April 10, 2026, accession 0001628280-26-024684, and prior-year filings. Open the filing on EDGAR.
How this page was built: the OCTAVE SPECIALTY GROUP INC filed document, accession 0001628280-26-024684. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 727,288 | $6,358,663 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in OCTAVE SPECIALTY GROUP INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
10 Form 4 lines since the FY2025 proxy (filed April 10, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-03 | Exercise or conversion derivative | — | 221,188 | $0.00 | 418,731 |
| 2026-10-03 | Exercise or conversion | — | 11,628 | — | 1,083,670 |
| 2026-10-03 | Tax withholding | — | 11,638 | $4.60 | 1,072,032 |
| 2026-10-03 | Exercise or conversion | — | 15,229 | — | 1,080,463 |
| 2026-10-03 | Tax withholding | — | 8,421 | $4.60 | 1,072,042 |
| 2026-10-03 | Exercise or conversion derivative | — | 15,229 | $0.00 | 465,603 |
| 2026-10-03 | Exercise or conversion derivative | — | 232,816 | $0.00 | 232,787 |
| 2026-07-09 | Exercise or conversion | — | 39,380 | — | 1,087,011 |
The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments OCTAVE SPECIALTY discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Death | $0 | $6,612,393 | $0 | $7,737,393 |
| Involuntary termination without cause | $4,050,000 | $3,640,783 | $58,650 | $8,874,433 |
| Voluntary resignation | $0 | $0 | $0 | $0 |
| Change in control and involuntary termination | $5,062,500 | $3,640,783 | $58,650 | $9,886,933 |
Per the Potential Payments Upon Termination or Change in Control table in OCTAVE SPECIALTY GROUP INC's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
OCTAVE SPECIALTY’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Claude LeBlanc · this page | President and Chief Executive Officer and Director | $10,356,228 |
| David Trick | Executive Vice President, Chief Financial Officer and Treasurer | $4,262,734 |
| Stephen Ksenak | Former Senior Managing Director and Chief Legal Officer | $3,704,762 |
| R. Sharon Smith | Executive Vice President and Group Chief Operating Officer | $3,559,351 |
| Daniel McGinnis | Former Senior Managing Director and Chief Operating Officer | $2,312,497 |
| Lawrence Metz | Senior Managing Director and General Counsel | $273,637 |
Board service
OCTAVE SPECIALTY board · FY2023–FY2025How this board is paid
Company policy: OCTAVE SPECIALTY pays directors a $100,000 cash retainer and $150,000 in RSUs. As stated in OCTAVE SPECIALTY's FY2025 proxy.
The full OCTAVE SPECIALTY compensation record
free company briefThis page is one person within OCTAVE SPECIALTY's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the OCTAVE SPECIALTY proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order OCTAVE SPECIALTY's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OCTAVE SPECIALTY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order OSG
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.